Annual Working Capital
$19.67 M
-$12.75 M-39.33%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual working capital is $19.67 million, with the most recent change of -$12.75 million (-39.33%) on December 31, 2023.
- During the last 3 years, RGLS annual working capital has fallen by -$5.48 million (-21.79%).
- RGLS annual working capital is now -84.84% below its all-time high of $129.76 million, reached on December 31, 2014.
Performance
RGLS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$85.20 M
-$9.87 M-10.38%
September 30, 2024
Summary
- As of February 8, 2025, RGLS quarterly working capital is $85.20 million, with the most recent change of -$9.87 million (-10.38%) on September 30, 2024.
- Over the past year, RGLS quarterly working capital has dropped by -$9.87 million (-10.38%).
- RGLS quarterly working capital is now -40.90% below its all-time high of $144.17 million, reached on March 31, 2015.
Performance
RGLS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RGLS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.3% | -10.4% |
| 3 y3 years | -21.8% | +87.0% |
| 5 y5 years | +367.6% | +5876.6% |
RGLS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.2% | at low | -11.0% | +333.1% |
| 5 y | 5-year | -67.2% | +4.6% | -11.0% | +1147.9% |
| alltime | all time | -84.8% | +367.6% | -40.9% | +1259.1% |
Regulus Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $85.20 M(-10.4%) |
| Jun 2024 | - | $95.08 M(-0.7%) |
| Mar 2024 | - | $95.77 M(+386.8%) |
| Dec 2023 | $19.67 M(-39.3%) | $19.67 M(-26.7%) |
| Sep 2023 | - | $26.83 M(-19.0%) |
| Jun 2023 | - | $33.13 M(+28.7%) |
| Mar 2023 | - | $25.74 M(-20.6%) |
| Dec 2022 | $32.42 M(-46.0%) | $32.42 M(-16.5%) |
| Sep 2022 | - | $38.85 M(-14.7%) |
| Jun 2022 | - | $45.57 M(-14.4%) |
| Mar 2022 | - | $53.23 M(-11.3%) |
| Dec 2021 | $60.01 M(+138.6%) | $60.01 M(+110.4%) |
| Sep 2021 | - | $28.53 M(-21.5%) |
| Jun 2021 | - | $36.34 M(+36.3%) |
| Mar 2021 | - | $26.67 M(+6.0%) |
| Dec 2020 | $25.15 M(+33.7%) | $25.15 M(+268.4%) |
| Sep 2020 | - | $6.83 M(-10.3%) |
| Jun 2020 | - | $7.61 M(-45.0%) |
| Mar 2020 | - | $13.82 M(-26.5%) |
| Dec 2019 | $18.81 M(-355.9%) | $18.81 M(-1375.2%) |
| Sep 2019 | - | -$1.48 M(-138.8%) |
| Jun 2019 | - | $3.80 M(-153.5%) |
| Mar 2019 | - | -$7.10 M(-3.4%) |
| Dec 2018 | -$7.35 M | -$7.35 M(+3351.2%) |
| Sep 2018 | - | -$213.00 K(-102.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $8.43 M(-58.9%) |
| Mar 2018 | - | $20.50 M(-40.0%) |
| Dec 2017 | $34.14 M(-53.7%) | $34.14 M(-49.7%) |
| Sep 2017 | - | $67.81 M(+74.7%) |
| Jun 2017 | - | $38.82 M(-32.0%) |
| Mar 2017 | - | $57.07 M(-22.5%) |
| Dec 2016 | $73.67 M(-39.4%) | $73.67 M(-17.9%) |
| Sep 2016 | - | $89.68 M(-14.7%) |
| Jun 2016 | - | $105.14 M(+0.4%) |
| Mar 2016 | - | $104.75 M(-13.9%) |
| Dec 2015 | $121.63 M(-6.3%) | $121.63 M(-0.3%) |
| Sep 2015 | - | $122.00 M(-5.8%) |
| Jun 2015 | - | $129.54 M(-10.1%) |
| Mar 2015 | - | $144.17 M(+11.1%) |
| Dec 2014 | $129.76 M(+21.5%) | $129.76 M(+50.7%) |
| Sep 2014 | - | $86.13 M(-10.9%) |
| Jun 2014 | - | $96.62 M(-11.1%) |
| Mar 2014 | - | $108.66 M(+1.7%) |
| Dec 2013 | $106.81 M(+24.0%) | $106.81 M(-4.4%) |
| Sep 2013 | - | $111.76 M(+64.7%) |
| Jun 2013 | - | $67.87 M(-14.2%) |
| Mar 2013 | - | $79.08 M(-8.2%) |
| Dec 2012 | $86.16 M(+233.8%) | $86.16 M(+311.2%) |
| Sep 2012 | - | $20.95 M(+93.9%) |
| Jun 2012 | - | $10.81 M(-58.1%) |
| Dec 2011 | $25.82 M | $25.82 M |
FAQ
- What is Regulus Therapeutics annual working capital?
- What is the all time high annual working capital for Regulus Therapeutics?
- What is Regulus Therapeutics annual working capital year-on-year change?
- What is Regulus Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly working capital year-on-year change?
What is Regulus Therapeutics annual working capital?
The current annual working capital of RGLS is $19.67 M
What is the all time high annual working capital for Regulus Therapeutics?
Regulus Therapeutics all-time high annual working capital is $129.76 M
What is Regulus Therapeutics annual working capital year-on-year change?
Over the past year, RGLS annual working capital has changed by -$12.75 M (-39.33%)
What is Regulus Therapeutics quarterly working capital?
The current quarterly working capital of RGLS is $85.20 M
What is the all time high quarterly working capital for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly working capital is $144.17 M
What is Regulus Therapeutics quarterly working capital year-on-year change?
Over the past year, RGLS quarterly working capital has changed by -$9.87 M (-10.38%)